Cart
sales@molnova.com
Methyliodobikinin
CAS No. 1186336-04-8
Methyliodobikinin( —— )
Catalog No. M10633 CAS No. 1186336-04-8
Methyliodobikinin is a potent bikinin-like inhibitor targeting GSK3/Shaggy-like kinase, shows improved cell permeability.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameMethyliodobikinin
-
NoteResearch use only, not for human use.
-
Brief DescriptionMethyliodobikinin is a potent bikinin-like inhibitor targeting GSK3/Shaggy-like kinase, shows improved cell permeability.
-
DescriptionMethyliodobikinin is a potent bikinin-like inhibitor targeting GSK3/Shaggy-like kinase, shows improved cell permeability, highly potent in vivo although it had lower activity in vitro; activates brassinosteroid (BR) signalling and mimic BR action, 3.4 times more active in vivo than bikinin.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayPI3K/Akt/mTOR signaling
-
TargetGSK-3
-
RecptorGSK-3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1186336-04-8
-
Formula Weight334.113
-
Molecular FormulaC10H11IN2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical NameMethyl 4-((5-iodopyridin-2-yl)amino)-4-oxobutanoate
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rozhon W, et al. BMC Plant Biol. 2014 Jun 19;14:172.
molnova catalog
related products
-
5-Iodo-indirubin-3-m...
5-Iodo-indirubin-3'-monoxime is a potent GSK-3β, CDK5/P25 and CDK1/cyclin B inhibitor, competing with ATP for binding to the catalytic site of the kinase (IC50s: 9, 20 and 25 nM).
-
CCG 203769
CCG 203769 is a selective inhibitor of RGS4 with an IC50 of 17 nM for the RGS4-Gαo protein-protein interaction.
-
GSK-3β inhibitor 12
GSK-3β inhibitor 12 is a selective GSK-3β inhibitor.GSK-3β inhibitor 12 inhibits 49.11% of 25 μM GSK-3β activity and 37.11% of 50 μM GSK-3β activity.
